Dr. Amanda Olson
Claim this profileM D Anderson Cancer Center
Studies Cancer
Studies Skin and Soft Tissue Infections
7 reported clinical trials
16 drugs studied
Area of expertise
1Cancer
-5/5q- positive
abn(3q) positive
-7/7q- positive
2Skin And Soft Tissue Infections
Affiliated Hospitals
Clinical Trials Amanda Olson is currently running
Adoptive Immunotherapy
for Viral Infections
This Phase I-II dose-finding trial to determine the optimal dose of intravenous (IV) injection dose of donor-derived cytotoxic T lymphocytes (CTLs) specific for CMV, EBV, BKV and Adenovirus. A maximum of 36 patients will be treated in up to 18 cohorts each of size 2, with the first cohort treated at the lowest dose level 1, all successive doses chosen by the EffTox method, and no untried dose level skipped when escalating. The scientific goal of the trial is to determine an optimal IV-CTL cell dose level among the three doses 1.0x107cells/m2, 2 x107cells/m2 and 5x107cells/m2., hereafter dose levels 1, 2, 3. Dose-finding will be done using the sequentially adaptive EffTox trade-off-based design of Thall et al.
Recruiting1 award Phase 1 & 25 criteria
Cytotoxic T Lymphocytes
for Virus-Related Cancer
This phase II trial studies how well donor cytotoxic T lymphocytes work in treating patients with malignancies with BK and/or JC virus. Cytotoxic T lymphocytes are made from donated blood cells that are grown in the laboratory and are designed to kill viruses that can cause infections in transplant patients and may be an effective treatment in patients with malignancies with BK and/or JC virus.
Recruiting1 award Phase 27 criteria
More about Amanda Olson
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Amanda Olson has experience with
- Mesenchymal Stem Cell Transplantation
- Allogeneic BK-specific Cytotoxic T-lymphocytes
- Allogeneic Natural Killer Cell Line NK-92
- CMV/AdV /EBV/BKV Specific T Cells
- Anti-Thymocyte Globulin
- Busulfan
Breakdown of trials Amanda Olson has run
Cancer
Skin and Soft Tissue Infections
Infections and Infestations
Viral Infections
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amanda Olson specialize in?
Amanda Olson focuses on Cancer and Skin and Soft Tissue Infections. In particular, much of their work with Cancer has involved -5/5q- positive patients, or patients who are abn(3q) positive.
Is Amanda Olson currently recruiting for clinical trials?
Yes, Amanda Olson is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Amanda Olson has studied deeply?
Yes, Amanda Olson has studied treatments such as Mesenchymal Stem Cell Transplantation, Allogeneic BK-specific Cytotoxic T-lymphocytes, Allogeneic Natural Killer Cell Line NK-92.
What is the best way to schedule an appointment with Amanda Olson?
Apply for one of the trials that Amanda Olson is conducting.
What is the office address of Amanda Olson?
The office of Amanda Olson is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.